D. Buckley et al., Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777, J PHARM B, 24(4), 2001, pp. 651-657
An unexpected degradation product, greater than 0.10%,was observed in a DMP
777 capsule formulation stored at 40 degreesC/75% r.h. for 3 months and 25
degreesC/60%: r.h. for 2 years. The degradant of interest was prepared in
quantity by refluxing the drug substance in dilute acid. A preparative HPLC
method was developed to separate the various degradants and to collect eac
h as a separate Fraction. Each Fraction was analyzed by the analytical HPLC
gradient test method to assure positive identification of each peak and to
correlate each peak to the original capsule sample. Key isolated degradati
on products were used for structure elucidation with mass spectrometry. and
NMR. The major degradant of interest in the capsule formulation was found
to be a carboxylic acid resulting from the acid hydrolysis of an amide bond
. (C) 2001 Published by Elsevier Science B.V. All rights reserved.